Orexin receptor antagonism: An ascending multiple-dose study with almorexant

Trial Profile

Orexin receptor antagonism: An ascending multiple-dose study with almorexant

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Sep 2012

At a glance

  • Drugs Almorexant (Primary)
  • Indications Insomnia
  • Focus Pharmacodynamics
  • Sponsors Actelion Pharmaceuticals
  • Most Recent Events

    • 07 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top